Vaccibody

a novel generation of vaccines

Vaccibody – a novel generation of vaccines

 Vaccibody develops a novel and more potent therapeutic vaccine strategy inducing a stronger immunization and T cell response (both CD4+ and CD8+) than conventional vaccine strategies. Through its innovative design Vaccibody’s proprietary vaccine platform generates a durable and broad antibody and the T-cell response leading to remarkably effective vaccines. 
The additional uniqueness of the Vaccibody platform  is the flexible format allowing a variety of different structures as targeting units as well as antigenic units. Vaccibody has the experience and know-how to customize the vaccines by intelligent choice of targeting unit to induce the desired immune response profile associated with protection for each specific disease.